Car­tel Coali­tion last Sat­ur­day may well be dri­ven by a gen­uine de­sire to con­front the grow­ing pow­er of transna­tion­al crim­i­nal car­tels.
The deal will help the company advance its lead candidate into clinical trials.
He previously admitted he was worried he was being written out when he found out about his reduced episode count.